Cargando…
Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies
Currently, the assessment of the neurobehavioral consequences of repeated cannabis use is restricted to studies in which brain function of chronic cannabis users is compared to that of non-cannabis using controls. The assumption of such studies is that changes in brain function of chronic users are...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046729/ https://www.ncbi.nlm.nih.gov/pubmed/35492732 http://dx.doi.org/10.3389/fpsyt.2022.870750 |
_version_ | 1784695574028615680 |
---|---|
author | Ramaekers, Johannes G. Theunissen, Eef L. van Ruitenbeek, Peter Mason, Natasha L. |
author_facet | Ramaekers, Johannes G. Theunissen, Eef L. van Ruitenbeek, Peter Mason, Natasha L. |
author_sort | Ramaekers, Johannes G. |
collection | PubMed |
description | Currently, the assessment of the neurobehavioral consequences of repeated cannabis use is restricted to studies in which brain function of chronic cannabis users is compared to that of non-cannabis using controls. The assumption of such studies is that changes in brain function of chronic users are caused by repeated and prolonged exposure to acute cannabis intoxication. However, differences in brain function between chronic cannabis users and non-users might also arise from confounding factors such as polydrug use, alcohol use, withdrawal, economic status, or lifestyle conditions. We propose a methodology that highlights the relevance of acute Δ(9)-tetrahydrocannabinol (THC) dosing studies for a direct assessment of neuroadaptations in chronic cannabis users. The approach includes quantification of neurochemical, receptor, and functional brain network changes in response to an acute cannabis challenge, as well as stratification of cannabis using groups ranging from occasional to cannabis-dependent individuals. The methodology allows for an evaluation of THC induced neuroadaptive and neurocognitive changes across cannabis use history, that can inform neurobiological models on reward driven, compulsive cannabis use. |
format | Online Article Text |
id | pubmed-9046729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90467292022-04-29 Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies Ramaekers, Johannes G. Theunissen, Eef L. van Ruitenbeek, Peter Mason, Natasha L. Front Psychiatry Psychiatry Currently, the assessment of the neurobehavioral consequences of repeated cannabis use is restricted to studies in which brain function of chronic cannabis users is compared to that of non-cannabis using controls. The assumption of such studies is that changes in brain function of chronic users are caused by repeated and prolonged exposure to acute cannabis intoxication. However, differences in brain function between chronic cannabis users and non-users might also arise from confounding factors such as polydrug use, alcohol use, withdrawal, economic status, or lifestyle conditions. We propose a methodology that highlights the relevance of acute Δ(9)-tetrahydrocannabinol (THC) dosing studies for a direct assessment of neuroadaptations in chronic cannabis users. The approach includes quantification of neurochemical, receptor, and functional brain network changes in response to an acute cannabis challenge, as well as stratification of cannabis using groups ranging from occasional to cannabis-dependent individuals. The methodology allows for an evaluation of THC induced neuroadaptive and neurocognitive changes across cannabis use history, that can inform neurobiological models on reward driven, compulsive cannabis use. Frontiers Media S.A. 2022-04-14 /pmc/articles/PMC9046729/ /pubmed/35492732 http://dx.doi.org/10.3389/fpsyt.2022.870750 Text en Copyright © 2022 Ramaekers, Theunissen, van Ruitenbeek and Mason. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Ramaekers, Johannes G. Theunissen, Eef L. van Ruitenbeek, Peter Mason, Natasha L. Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies |
title | Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies |
title_full | Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies |
title_fullStr | Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies |
title_full_unstemmed | Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies |
title_short | Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies |
title_sort | cannabis use and neuroadaptation: a call for δ(9)-tetrahydrocannabinol challenge studies |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9046729/ https://www.ncbi.nlm.nih.gov/pubmed/35492732 http://dx.doi.org/10.3389/fpsyt.2022.870750 |
work_keys_str_mv | AT ramaekersjohannesg cannabisuseandneuroadaptationacallford9tetrahydrocannabinolchallengestudies AT theunisseneefl cannabisuseandneuroadaptationacallford9tetrahydrocannabinolchallengestudies AT vanruitenbeekpeter cannabisuseandneuroadaptationacallford9tetrahydrocannabinolchallengestudies AT masonnatashal cannabisuseandneuroadaptationacallford9tetrahydrocannabinolchallengestudies |